Stock Analysis on Net

Gilead Sciences Inc. (NASDAQ:GILD)

$24.99

Analysis of Goodwill and Intangible Assets

Microsoft Excel

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Goodwill and Intangible Asset Disclosure

Gilead Sciences Inc., balance sheet: goodwill and intangible assets

US$ in millions

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Goodwill
Sofosbuvir
Axicabtagene ciloleucel
Trodelvy
Hepcludex
Other
Finite-lived assets, gross carrying amount
Accumulated amortization
Finite-lived assets, net carrying amount
IPR&D
Indefinite-lived assets
Intangible assets
Goodwill and intangible assets

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).


Goodwill remained relatively stable between 2021 and 2025, consistently reported at approximately US$8.3 billion. Significant fluctuations are observed within the intangible asset portfolio, particularly concerning specific assets and the overall value of indefinite-lived assets. A notable trend is the decreasing value of Intangible assets and Goodwill and intangible assets over the five-year period.

Goodwill
Goodwill exhibited minimal change throughout the period, remaining at US$8,332 million in 2021, decreasing slightly to US$8,314 million in 2022, and holding steady at that level through 2025. This suggests no significant acquisitions or impairments impacting goodwill during this timeframe.
Key Intangible Assets – Individual Trends
Sofosbuvir and Axicabtagene ciloleucel maintained constant values of US$10.72 billion and US$7.11 billion, respectively, across all years. Trodelvy experienced a substantial increase in value from US$5.63 billion in 2021 and 2022 to US$11.73 billion in 2023, remaining at that level through 2025. Hepcludex remained consistently valued at US$845 million. The ‘Other’ intangible asset category decreased from US$1.611 billion in 2021 to US$1.483 billion in 2025.
Finite-Lived Intangible Assets
The gross carrying amount of finite-lived assets increased from US$25.916 billion in 2021 to US$31.888 billion in 2025. However, accumulated amortization increased significantly, moving from negative US$8.381 billion in 2021 to negative US$17.210 billion in 2025. Consequently, the net carrying amount of finite-lived assets decreased from US$17.535 billion in 2021 to US$14.678 billion in 2025, despite the increase in the gross carrying amount. This indicates a faster rate of amortization than asset acquisition.
Indefinite-Lived Assets & IPR&D
Indefinite-lived assets, which are equivalent to IPR&D in this presentation, experienced a substantial decline. Starting at US$15.92 billion in 2021, they decreased to US$2.3 billion by 2025. This represents a significant reduction in the value of assets with indefinite useful lives, potentially due to impairment charges or changes in valuation assumptions.
Total Intangible Assets
Total intangible assets decreased from US$33.455 billion in 2021 to US$16.978 billion in 2025. This decline is primarily driven by the reduction in indefinite-lived assets and, to a lesser extent, the net carrying amount of finite-lived assets.
Goodwill and Intangible Assets Combined
The combined value of goodwill and intangible assets decreased from US$41.787 billion in 2021 to US$25.292 billion in 2025. This overall reduction reflects the combined effect of the trends observed in both goodwill and the various intangible asset categories.

Adjustments to Financial Statements: Removal of Goodwill

Gilead Sciences Inc., adjustments to financial statements

US$ in millions

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Adjustment to Total Assets
Total assets (as reported)
Less: Goodwill
Total assets (adjusted)
Adjustment to Total Gilead Stockholders’ Equity
Total Gilead stockholders’ equity (as reported)
Less: Goodwill
Total Gilead stockholders’ equity (adjusted)

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).


An examination of the financial information reveals a consistent difference between reported and adjusted total assets and stockholders’ equity over the five-year period. The adjustments appear to be primarily related to the removal of goodwill and intangible assets, resulting in significantly lower values for the adjusted figures.

Total Assets Trend
Reported total assets decreased from US$67,952 million in 2021 to US$58,995 million in 2024, before a slight increase to US$59,023 million in 2025. Adjusted total assets demonstrate a more pronounced decline, moving from US$59,620 million in 2021 to US$50,681 million in 2024, with a similar modest increase to US$50,709 million in 2025. The difference between reported and adjusted assets widens over time, indicating a cumulative effect from the adjustments.
Stockholders’ Equity Trend
Reported total stockholders’ equity fluctuates over the period, increasing from US$21,069 million in 2021 to US$22,833 million in 2023, then decreasing to US$19,330 million in 2024, and recovering to US$22,703 million in 2025. Adjusted stockholders’ equity also exhibits a decreasing trend from US$12,737 million in 2021 to US$11,016 million in 2024, followed by an increase to US$14,389 million in 2025. The gap between reported and adjusted equity is substantial and remains relatively consistent, suggesting a significant portion of reported equity is attributable to goodwill and intangible assets.
Adjustment Impact
The adjustments consistently reduce both total assets and stockholders’ equity. In 2021, the adjustments reduced total assets by approximately US$8,332 million and stockholders’ equity by approximately US$8,332 million. By 2024, the adjustments reduced total assets by approximately US$9,176 million and stockholders’ equity by approximately US$8,314 million. This suggests the cumulative impact of removing goodwill and intangible assets is growing over time. The 2025 figures show a slight moderation in the asset adjustment, but a continued substantial adjustment to equity.

The consistent and material adjustments to both total assets and stockholders’ equity highlight the importance of understanding the composition of these figures. The removal of goodwill and intangible assets significantly alters the financial picture, potentially impacting key financial ratios and metrics used for valuation and performance assessment.


Gilead Sciences Inc., Financial Data: Reported vs. Adjusted


Adjusted Financial Ratios: Removal of Goodwill (Summary)

Gilead Sciences Inc., adjusted financial ratios

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Total Asset Turnover
Reported total asset turnover
Adjusted total asset turnover
Financial Leverage
Reported financial leverage
Adjusted financial leverage
Return on Equity (ROE)
Reported ROE
Adjusted ROE
Return on Assets (ROA)
Reported ROA
Adjusted ROA

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).


The financial metrics demonstrate a consistent divergence between reported and adjusted values following the removal of goodwill and intangible assets. This adjustment impacts asset utilization, financial leverage, and profitability ratios, revealing a potentially different operational and financial profile than initially indicated by reported figures.

Total Asset Turnover
Reported total asset turnover exhibited a modest increase from 0.40 in 2021 to 0.49 in 2025. However, the adjusted total asset turnover consistently exceeded the reported value, increasing from 0.45 to 0.57 over the same period. This suggests that excluding goodwill and intangible assets reveals a more efficient utilization of operating assets. The difference between reported and adjusted values widened slightly over time, indicating a growing proportion of assets represented by goodwill and intangibles.
Financial Leverage
Reported financial leverage decreased from 3.23 in 2021 to 2.60 in 2025, with some fluctuation. Conversely, adjusted financial leverage was notably higher, starting at 4.68 in 2021 and decreasing to 3.52 in 2025. This indicates that the company’s debt levels appear more substantial when goodwill and intangible assets are excluded from the asset base. The adjusted leverage ratio also experienced fluctuations, mirroring the reported trend but at a higher magnitude.
Return on Equity (ROE)
Reported ROE experienced significant volatility, declining sharply in 2022 before recovering substantially in 2025. The adjusted ROE consistently presented a higher value than the reported ROE across all periods, starting at 48.87% in 2021 and increasing to 59.14% in 2025. This suggests that the profitability attributable to shareholders is considerably higher when goodwill and intangible assets are removed from the calculation. The adjusted ROE demonstrates a more consistent upward trend than the reported ROE.
Return on Assets (ROA)
Reported ROA also showed volatility, with a decline in 2022 and a substantial increase in 2025. The adjusted ROA consistently exceeded the reported ROA, moving from 10.44% in 2021 to 16.78% in 2025. This indicates that the company generates a higher return on its operating assets when goodwill and intangible assets are excluded. The adjusted ROA, similar to ROE, exhibits a more stable positive trend.

In summary, the adjustments reveal a company with higher asset utilization, greater financial leverage, and improved profitability metrics than indicated by the reported financial statements. The increasing divergence between reported and adjusted figures suggests a growing reliance on goodwill and intangible assets in the reported asset base.


Gilead Sciences Inc., Financial Ratios: Reported vs. Adjusted


Adjusted Total Asset Turnover

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
As Reported
Selected Financial Data (US$ in millions)
Product sales
Total assets
Activity Ratio
Total asset turnover1
Adjusted for Goodwill
Selected Financial Data (US$ in millions)
Product sales
Adjusted total assets
Activity Ratio
Adjusted total asset turnover2

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

2025 Calculations

1 Total asset turnover = Product sales ÷ Total assets
= ÷ =

2 Adjusted total asset turnover = Product sales ÷ Adjusted total assets
= ÷ =


An examination of the financial information reveals trends in both total asset values and associated turnover ratios over a five-year period. Reported total assets decreased from 2021 to 2024, exhibiting a cumulative decline, before stabilizing in 2025. Adjusted total assets followed a similar pattern, decreasing consistently from 2021 to 2024 and remaining relatively stable in 2025. The adjusted total asset turnover ratio demonstrates a generally increasing trend, while the reported total asset turnover ratio shows a more moderate increase.

Reported Total Assets
Reported total assets began at US$67,952 million in 2021 and decreased to US$58,995 million in 2024. This represents a reduction of approximately 13.2%. The value remained consistent at US$59,023 million in 2025, suggesting a potential stabilization after the prior decline.
Adjusted Total Assets
Adjusted total assets experienced a more pronounced decrease, moving from US$59,620 million in 2021 to US$50,681 million in 2024, a decrease of approximately 15.1%. Similar to reported total assets, adjusted total assets showed stability in 2025, ending the period at US$50,709 million.
Reported Total Asset Turnover
The reported total asset turnover ratio increased from 0.40 in 2021 to 0.49 in 2025. While demonstrating an upward trend, the increase was gradual, with a more noticeable jump from 0.43 in 2022 and 2023 to 0.48 in 2024. This suggests improving efficiency in generating revenue from reported assets, but at a moderate pace.
Adjusted Total Asset Turnover
The adjusted total asset turnover ratio exhibited a stronger upward trend, rising from 0.45 in 2021 to 0.57 in 2025. The ratio increased consistently each year, with a more significant increase from 0.50 in 2023 to 0.56 in 2024. This indicates a more substantial improvement in revenue generation when considering the adjusted asset base. The difference between the reported and adjusted turnover ratios widens over time, suggesting that the adjustments to total assets are impacting the efficiency metric.

The consistent decline in both reported and adjusted total assets, coupled with the increasing turnover ratios, suggests that the company is becoming more efficient in utilizing its asset base to generate revenue. The more significant increase in the adjusted total asset turnover ratio implies that the adjustments made to total assets are revealing a more accurate picture of asset utilization efficiency.


Adjusted Financial Leverage

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
As Reported
Selected Financial Data (US$ in millions)
Total assets
Total Gilead stockholders’ equity
Solvency Ratio
Financial leverage1
Adjusted for Goodwill
Selected Financial Data (US$ in millions)
Adjusted total assets
Adjusted total Gilead stockholders’ equity
Solvency Ratio
Adjusted financial leverage2

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

2025 Calculations

1 Financial leverage = Total assets ÷ Total Gilead stockholders’ equity
= ÷ =

2 Adjusted financial leverage = Adjusted total assets ÷ Adjusted total Gilead stockholders’ equity
= ÷ =


An examination of the financial information reveals trends in both reported and adjusted asset and equity figures, impacting calculated financial leverage ratios over the five-year period. Reported total assets decreased from 2021 to 2024, before stabilizing in 2025. A more pronounced decrease is observed in adjusted total assets throughout the period, suggesting a reduction in assets after accounting for specific adjustments. Stockholders’ equity, as reported, fluctuates, with increases in 2022 and 2023, a decrease in 2024, and a subsequent increase in 2025. Adjusted stockholders’ equity follows a similar pattern, though the magnitudes of change differ.

Reported Financial Leverage
Reported financial leverage decreased from 3.23 in 2021 to 2.72 in 2023, indicating a lessening of financial risk based on reported figures. However, it increased to 3.05 in 2024 before decreasing again to 2.60 in 2025. This suggests a fluctuating relationship between reported assets and equity.
Adjusted Financial Leverage
Adjusted financial leverage exhibits a decline from 4.68 in 2021 to 3.71 in 2023. This indicates a reduction in financial risk when considering the adjustments made to total assets and equity. A subsequent increase to 4.60 in 2024 is observed, followed by a decrease to 3.52 in 2025. The adjusted leverage ratio consistently remains higher than the reported leverage ratio throughout the period, suggesting that the adjustments significantly impact the assessment of financial risk.

The divergence between reported and adjusted financial leverage highlights the importance of understanding the nature of the adjustments being made. The consistent difference suggests that goodwill and intangible assets, or other items impacting the adjustments, represent a substantial portion of the company’s reported assets and equity. The increase in adjusted financial leverage in 2024, despite a decrease in reported leverage, warrants further investigation into the specific adjustments made during that year.

Asset and Equity Trends
The consistent decrease in adjusted total assets, coupled with fluctuations in adjusted stockholders’ equity, contributes to the volatility observed in adjusted financial leverage. The stabilization of reported total assets in 2025, alongside an increase in reported stockholders’ equity, may indicate a shift in the company’s asset and equity structure.

Overall, the analysis indicates a dynamic financial position with notable differences between reported and adjusted financial leverage. Continued monitoring of these trends, along with a detailed understanding of the adjustments applied, is crucial for a comprehensive assessment of the company’s financial risk profile.


Adjusted Return on Equity (ROE)

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
As Reported
Selected Financial Data (US$ in millions)
Net income attributable to Gilead
Total Gilead stockholders’ equity
Profitability Ratio
ROE1
Adjusted for Goodwill
Selected Financial Data (US$ in millions)
Net income attributable to Gilead
Adjusted total Gilead stockholders’ equity
Profitability Ratio
Adjusted ROE2

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

2025 Calculations

1 ROE = 100 × Net income attributable to Gilead ÷ Total Gilead stockholders’ equity
= 100 × ÷ =

2 Adjusted ROE = 100 × Net income attributable to Gilead ÷ Adjusted total Gilead stockholders’ equity
= 100 × ÷ =


Analysis of the presented financial information reveals notable fluctuations in both reported and adjusted stockholders’ equity, alongside corresponding variations in return on equity (ROE) over the five-year period. A significant divergence exists between reported and adjusted ROE values, suggesting the impact of adjustments made to stockholders’ equity.

Stockholders’ Equity Trends
Reported total stockholders’ equity generally increased from 2021 to 2023, peaking at US$22,833 million, before experiencing a substantial decrease in 2024 to US$19,330 million. A partial recovery is observed in 2025, with equity reaching US$22,703 million. Adjusted total stockholders’ equity follows a similar pattern, increasing through 2023 to US$14,519 million, declining sharply in 2024 to US$11,016 million, and then increasing again in 2025 to US$14,389 million. The magnitude of the decrease in 2024 is more pronounced when considering the adjusted equity figure.
Reported Return on Equity (ROE)
Reported ROE demonstrates considerable volatility. It begins at 29.55% in 2021, decreases to 21.62% in 2022, rises to 24.81% in 2023, then plummets to a low of 2.48% in 2024. A substantial increase is then seen in 2025, with ROE reaching 37.48%. This fluctuation closely mirrors the changes observed in reported stockholders’ equity.
Adjusted Return on Equity (ROE)
Adjusted ROE exhibits a similar pattern of fluctuation, but at consistently higher levels than the reported ROE. Starting at 48.87% in 2021, it declines to 35.53% in 2022 and 39.02% in 2023. The most significant drop occurs in 2024, falling to 4.36%, mirroring the decline in adjusted equity. A dramatic recovery is observed in 2025, with adjusted ROE increasing to 59.14%. The consistently higher adjusted ROE suggests that the adjustments to stockholders’ equity significantly impact profitability metrics.

The substantial decrease in both adjusted equity and adjusted ROE in 2024 warrants further investigation to understand the underlying factors contributing to this decline. The subsequent recovery in 2025 is also noteworthy and requires analysis to determine its sustainability. The difference between reported and adjusted ROE highlights the importance of understanding the nature of the adjustments made to stockholders’ equity when evaluating the company’s financial performance.


Adjusted Return on Assets (ROA)

Microsoft Excel
Dec 31, 2025 Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
As Reported
Selected Financial Data (US$ in millions)
Net income attributable to Gilead
Total assets
Profitability Ratio
ROA1
Adjusted for Goodwill
Selected Financial Data (US$ in millions)
Net income attributable to Gilead
Adjusted total assets
Profitability Ratio
Adjusted ROA2

Based on: 10-K (reporting date: 2025-12-31), 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31).

2025 Calculations

1 ROA = 100 × Net income attributable to Gilead ÷ Total assets
= 100 × ÷ =

2 Adjusted ROA = 100 × Net income attributable to Gilead ÷ Adjusted total assets
= 100 × ÷ =


The analysis reveals fluctuations in both reported and adjusted return on assets (ROA) over the five-year period. Reported total assets decreased from 2021 to 2024, exhibiting a cumulative decline, before stabilizing in 2025. A similar pattern is observed in adjusted total assets, which also decreased from 2021 to 2024 and then showed minimal change in 2025.

Reported ROA
Reported ROA began at 9.16% in 2021, decreased to 7.27% in 2022, and then recovered to 9.12% in 2023. A significant drop to 0.81% occurred in 2024, followed by a substantial increase to 14.42% in 2025. This indicates considerable volatility in profitability relative to reported assets.
Adjusted ROA
Adjusted ROA followed a similar trend to reported ROA, starting at 10.44% in 2021, declining to 8.37% in 2022, and increasing to 10.53% in 2023. It experienced a sharp decrease to 0.95% in 2024, mirroring the trend in reported ROA, and then rose significantly to 16.78% in 2025. The adjusted ROA consistently exceeded the reported ROA throughout the period.

The convergence of the reported and adjusted ROA trends, particularly the pronounced declines in 2024 and subsequent recoveries in 2025, suggests that changes in the adjustments to total assets are correlated with overall profitability. The difference between reported and adjusted ROA highlights the impact of specific asset adjustments on the perceived financial performance. The substantial increase in both ROA metrics in 2025 warrants further investigation to determine the underlying drivers of this improvement.

Asset Trends
Both reported and adjusted total assets demonstrate a consistent downward trend from 2021 through 2024. The stabilization of assets in 2025 may indicate a bottoming out of asset reduction or a shift in asset allocation strategy. The consistent difference between reported and adjusted total assets suggests the presence of significant adjustments, potentially related to goodwill or intangible assets, that impact the overall asset base.